Novel tracer for prostate cancer improves sensitivity

Article

A new radiotracer, FACBC, may help identify presence or absence of focal neoplastic involvement in patients with prostate cancer, according to work conducted at Emory University.

A new radiotracer, FACBC, may help identify presence or absence of focal neoplastic involvement in patients with prostate cancer, according to work conducted at Emory University. Researchers using the tracer demonstrated its uptake in both primary and metastatic prostate cancer on initial staging, as well as in recurrent cancer within the prostate bed, lymph nodes, and bone. The findings were reported in the January issue of the Journal of Nuclear Medicine.

Dr. David M. Schuster and colleagues evaluated nine patients with a recent diagnosis of prostate cancer and six with suspected recurrence. In eight of the newly diagnosed patients who underwent dynamic scanning, visual analysis correctly identified the presence or absence of focal neoplastic involvement in 40 of 48 prostate sextants. Pelvic nodal status correlated with FACBC findings in seven of nine patients and was indeterminate in two.

In all four patients with proven recurrence, researchers identified disease. In three of these patients, indium-111 ProstaScint had no significant uptake at nodal and skeletal foci.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.